secwatch.observer — SEC 8-K summary
======================================

Issuer:     NKGen Biotech, Inc. (—)
CIK:        0001845459
Form:       8-K
Filed at:   2023-05-23T23:59:59+00:00
Accession:  0001104659-23-063294
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Graf Acquisition Corp. IV extends deadline to Sept 29, 2023; $113.3M redeemed
-----------------------------------------------------------------------------

- Special meeting on May 22, 2023 approved extension of initial business combination deadline to September 29, 2023.
- Vote: 17,513,683 for, 1,057 against, 0 abstentions.
- Holders of 11,078,000 shares redeemed at ~$10.227 per share, aggregate $113.3 million.
- Post-redemption trust account balance is approximately $62.2 million.
- Charter amendment filed with Delaware Secretary of State.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845459/000110465923063294/0001104659-23-063294-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845459/000110465923063294/tm2316500d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-063294

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer